In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated ...

Express Scripts, Inc. is a pharmacy benefit management (PBM) operating in North America, offering a range of services to its clients, which include health maintenance organizations (HMOs), health ...

The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...

The completion of the Proposed Transaction is subject to the fulfilment, or waiver, of certain conditions, including board approvals, regulatory approvals, a satisfactory due diligence process, and ...

Cigna Group’s pharmacy benefit manager Express Scripts on Tuesday sued the U.S. Federal Trade Commission, alleging that the ...

Express Scripts is suing the Federal Trade Commission (FTC), demanding the retraction of a report it claims is false and harmful to the pharmacy benefit manager (PBM) industry. Express Scripts is ...

Psychedelic Biotech Psyence Grows Pipeline With Trials And Psilocybin Drug Developer Acquisition Psyence Biomed launches Phase IIb trials for psilocybin in palliative care and Alcohol Use Disorder ...

Opinions expressed by Forbes Contributors are their own. I write about business model strategy and execution across healthcare. On the heels of the FTC’s investigation into pharmacy benefit ...

"The call for increased regulatory oversight of PBM business practices is overwhelmingly welcomed by physicians as a check against possible anticompetitive harm resulting from low competition and high ...

PBM stock is up 162.6% as of Thursday morning. The stock was down 83.3% year-to-date when markets closed yesterday. Investors will want to keep reading for more of the most recent stock market ...

Express Scripts by Evernorth, a unit of Cigna Group (CI), Tuesday said it has filed a lawsuit against the Federal Trade Commission or ...

Cigna's Express Scripts, one of the country's largest pharmacy benefit managers, today sued the Federal Trade Commission and ...